NIH Funding Opportunities and Notices for March 22, 2019 (The NIH Guide TOC)

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest.

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts March 22, 2019 Table of Contents (TOC) Web Version

Notices

• Notice of Change to PAR-17-054, "Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01)"
  (NOT-AG-19-015)
  National Institute on Aging
• Notice of a Pre-Application Webinar for RFA-CA-19-034, Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)
  (NOT-CA-19-036)
  National Cancer Institute
• Notice to Extend the Expiration Date for PAR-18-103, Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03 Clinical Trial Optional)
  (NOT-DK-19-012)
  National Institute of Diabetes and Digestive and Kidney Diseases
• Notice of Change to Evaluation of Plans for Training in Methods for Enhancing Reproducibility in NIGMS Training Grant Funding Opportunity Announcements
  (NOT-GM-19-026)
  National Institute of General Medical Sciences
• Notice to Clarify that NIGMS Will Not Accept Applications to Support Scientific Courses through PA-18-648 "Support of Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"
  (NOT-GM-19-027)
  National Institute of General Medical Sciences
• Notice of Pre-Application Webinar for PAR-19-219 "Maximizing Access to Research Careers (MARC) (T34) 
  (NOT-GM-19-029)
  National Institute of General Medical Sciences
• NICHD Data and Specimen Hub (DASH) Releases New Functionality for Biospecimen Requests (NOT-HD-19-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
• Notice of Change in the Number of Trainee Slots on NHGRI T32 Postdoctoral Training Program in Genomic Medicine Research
  (NOT-HG-19-018)
  National Human Genome Research Institute
• Notice of Special Interest (NOSI): Computational and Statistical Methods to Enhance Discovery from Health Data
  (NOT-LM-19-003)
  National Library of Medicine
• Notice of Change to Allowable Appendix Materials for PAR-17-312 "NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25)"
  (NOT-NS-19-048)
  National Institute of Neurological Disorders and Stroke

Requests for Applications

• Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
  (RFA-AI-19-014)
  National Institute of Allergy and Infectious Diseases Application Receipt Date(s): July 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional)
  (RFA-AI-19-015)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 8, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
  (RFA-DK-19-003)
  National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): July 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed)
  (RFA-FD-19-018)
  Food and Drug Administration
  Application Receipt Date(s): May 21, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Novel Approaches to Translational Evidence Generation to Advance Coordinated Registry Networks (CRNs) via Big Data Analytics Using Disparate Data Sources (U01 Clinical Trial Optional)
  (RFA-FD-19-020)
  Food and Drug Administration Application Receipt Date(s): May 28, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
  (RFA-HD-20-005)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): June 27, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
• Using Data Analytics to Support Primary Care and Community Interventions to Improve Chronic Disease Prevention and Management and Population Health (R18)
  (RFA-HS-19-002)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01)
  (RFA-HS-19-003)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Program Announcements

• Behavioral and Social Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Optional)
  (PA-19-226)
  National Institute on Aging
  Application Receipt/Submission Date(s): May 6, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
  (PAR-19-222)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Human Genome Research Institute
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
  (PAR-19-223)
  National Institute on Drug Abuse
  Application Receipt/Submission Date(s): October 21, 2019, October 19, 2020, October 19, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
  (PAR-19-225)
  National Institute of Environmental Health Sciences
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Institutional Translational Research Training Program (T32)
  (PAR-19-228)
  National Institute of Neurological Disorders and Stroke
  Application Receipt/Submission Date(s): May 29, 2019; May 27, 2020; May 26, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)
  (PAR-19-229)
  National Institute of Allergy and Infectious Diseases
  Application Receipt/Submission Date(s): October 1, 2019; October 1, 2020; October 1, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.